Team publications 2022
1. DURAND S, SEIGNEURET F, BURLAUD-GAILLARD J, LEMOINE R, TASSI M, MOREAU A, MOUGEL M, ROINGEARD P, TAUBER C, ROCQUIGNY H. Revisiting formation of nucleoprotein complexes between HIV-1 Gag and genomic RNA during virus assembly by transmission electron microscopy. J Biol Chem 2022 ; 298: 101500.
2. BEAUMONT E*, LAROCHETTE V*, PRESSER L, MIOT C, PIGNON P, BLANCHARD S, HANSEN BJ, DAUVÉ J, POLI C, PORANEN M, LAMOURETTE P, PLAISANCE M MOREL A, FICKENSCHER H, JEANNIN P, ROINGEARD P*, DELNESTE Y*. IL-26 inhibits hepatitis C virus replication in hepatocytes. J Hepatol 2022 ; 76: 822-831.
3. MALLET C, COCHARD J, LECLERCQ S, TRAPP-FRAGNET L, CHOUTEAU P, DENESVRE C. Hypoxia and HIF-1 Trigger Marek's Disease Virus Reactivation in Lymphoma-Derived Latently Infected T Lymphocytes. J Virol 2022; 96: e0142721.
4. DUFLOO J, PLANCHAIS C, FRÉMONT S, LORIN V, GUIVEL-BENHASSINE, STEFIC K, CASARTELLI N, ECHARD A, ROINGEARD P, MOUQUET H SCHWARTZ O, BRUEL T. Anti-HIV-1 broadly neutralizing antibodies tether viral particles at the surface of infected cells. Nature Com 2022 ; 13:630.
5. HERRSCHER C, EYMIEUX S, GABORIT C, BLASCO H, MARLET J, STEFIC K, ROINGEARD P, GRAMMATICO-GUILLON L, HOURIOUX C. ELISA-based analysis reveals an anti-SARC-CoV-2 protein immune response profile associated with disease severity. J Clin Med 2022 : 11:405.
6. DELAYE JB, ALARCAN H, VALLET N, VEYRAT-DUREBEX C, BERNARD L, HÉRAULT O, ROPERT M, MARLET J, GYAN E, ANDRES C, BLASCO H, PIVER E. Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2. J Investig Med 2022; 70:934-938.
7. LORIN V, FERNÁNDEZ I, MASSE-RANSON G, BOUVIN-PLEY M, MOLINOS-ALBERT LM, PLANCHAIS C, HIEU T, PÉHAU-ARNAUDET G, HREBÍK D, GIRELLI-ZUBANI G, FIQUET O, GUIVEL-BENHASSINE F, SANDERS RW, WALKER BD, SCHWARTZ O, SCHEID JF, DIMITROV JD, PLEVKA P, BRAIBANT M, SEAMAN MS, BONTEMS F, DI SANTO JP, REY FA, MOUQUET H. Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller. J Exp Med 2022, 219:e20212045.
8. WANG C, SCHLUB TE, YU WH, TAN CS, STEFIC K, GIANELLA S, SMITH DM, LAUFFENBURGER DA, CHAILLON A, JULG B. Landscape of HIV neutralization susceptibilities across tissue reservoirs. Clin Infect Dis 2022, in press
9. ZHONG L, SONG Y, MARZIALI F, UZBEKOV R, NGUYEN X-N, JOURNO C, ROINGEARD P, CIMARELLI A. A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway. Life Sci Alliance 2022, 5, e202101174.
10. TREGUIER Y, BULL-MAURER A, ROINGEARD P. Apolipoprotein E, a crucial cellular protein in the lifecycle of hepatitis viruses. Int J Molec Sci 2022, 23:3676.
11. ZERBIB Y, GUILAIN N, EYMIEUX S, UZBEKOV R, CASTELLAIN S, BLANCHARD E, FRANÇOIS C, CHATELAIN D, BRAULT C, MAIZEL J, ROINGEARD P, SLAMA M. Pathology assessments of multiple organs in fatal COVID-19 in ICU vs non-ICU patients. Front Med (Lausanne) 2020, 9:837258.
12. AICHER S-M, STRIECHER F, CHAZAL M, PLANAS D, LUO D, BUCHRIESER J, NEMCOVA M, SEIDLOVA V, ZUKAL J, SERRA-COBO J, PONTIER D, PAIN B, ZIMMER G, SCHWARTZ O, ROINGEARD P, PIKULA J, DACHEUX L, JOUVENENT N. Species-specific molecular barriers to SARS-CoV-2 replication in bat cells. J Virol 2022, 96, e0060822.
13. EYMIEUX S, HOURIOUX C, MARLET J, MOREAU A, PATIENT R, D'ALTEROCHE L, GAUDY-GRAFFIN C, BLANCHARD E, ROINGEARD P. A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype. J Viral Hepat 2022, 29, 719-726.
14. ROINGEARD P, EYMIEUX S, BURLAUD-GAILLARD J, HOURIOUX C, PATIENT R, BLANCHARD E. The double-membrane vesicle (DMV) : a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses. Cell Mol Life Sci 2022, 79:425.
15. NICOLAS A, MIGRAINE J, DUTRIEUX J, SALMONA M, TAUZIN A, HACHIYA A, ESTAQUIER J, MOLINA JM, CLAVEL F, HANCE AJ, MAMMANO F. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients. Microbiol Spectr 2022, e0078422.
16. TRÉGUIER Y, COCHARD J, BURLAUD-GAILLARD J, LEMOINE R, CHOUTEAU P, ROINGEARD P, MEUNIER J-C, MAQUART M. The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particle. Virology J 2022, 19:124.
17. ANDRÉ S, PICARD M, CEZAR ., ROUX-DALVAI F, ALLEAUME-BUTEAUX A, SOUNDARAMOURTY C, SANTA CRUZ A, MENDES-FRIAS A, GOTTI C, LECLERCQ ., NICOLAS A, TAUZIN A, CARVALHO A, CAPELA C, PEDROSA J, GIL CASTRO A, KUNDURA L, LOUBET P, SOTTO A, MULLER L. LEFRANT J-Y, ROGER C, CLARET P-G, DUVNJAK S, TRAN T-A, RACINE G, ZGHIDI-ABOUZID O, NIOCHE P, SILVESTRE R, DROIT A, MAMMANO F, CORBEAU P, AND ESTAQUIER J T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ 2022, 29:1486-1499.
18. ANDRE S, AZARIAS DA SILVA M, PICARD M, ALLEAUME-BUTEAU A, KUNDURA L, CEZAR R, SOUNDARAMOURTY C, SANTA CRUZ A, MENDES-FRIAS A, CARVALHO A, CAPELA C, PEDROSA J, GIL CASTRO A, LOUBET P, MULLER L, SOTTO A, LEFRANT J-Y, ROGER C, CLARET P-G, DUVNJAK S, TRAN T-H, ZGHIDI-ABOUZID O, NIOCHE P, SILVESTRE R, CORBEAU P, MAMMANO F, ESTAQUIER J. Low quantity and quality of anti-spike humoral response is linked to CD4 T cell apoptosis in COVID-19 patients. Cell Death Disease, 2022, 13:741.
19. ZOLADEK J, BURLAUD-GAILLARD J, CHAZAL M, DESGRAUPES S, JEANNIN P, GESSAIN A, PARDIGON N, HUBERT M, ROINGEARD P, JOUVENET N, AFONSO P. Human claudin-derived peptides inhibit the fusion process of Zika virus and are broad Flavivirus inhibitors. Microbiology Spectrum 2022, 10:e0298922.
20. GALLO G, KOTLIK P, ROINGEARD P, MONOT M, CHEVREUX G, ULRICH RG, TORDO N, ERMONVAL M. The diverse susceptibilities and responses of human and rodent cells to orthohantavirus infection reveal different levels of cellular restriction. PloS Negl Trop Dis 2022, 16: e0010844.
21. BOYARD J, CAILLE A, BRUNET-HOUDARD S, SENGCHANH-VIDAL S, GIRAUDEAU B, MARRET H, ROLLAND-LOZACHMEUR G, RUSCH E, GAUDY-GRAFFIN C, HAGUENOER K. A home-mailed versus general practitioner-delivered vaginal self-sampling kit for cervical cancer screening: a cluster randomized controlled trial with a cost-effectiveness analysis. J Womens Health (Larchmt) 2022, 31:1472-1480.
22. MANRY J, BASTARD P, GERVAIS A,... (100 co-authors), MARLET J, ....(71 co-authors), Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A. Proc Natl Acad Sci USA 2022, 119: e2200413119.
23. BENTALEB C, HERVOUET K, MONTPELLIER C, CAMUZEL C, FERRIÉ M, BURLAUD-GAILLARD J, BRESSANELLI S, METZGER K, WERKMEISTER E, ANKAVAY M, LEON-JANAMPA N, MARLET J, ROUX J, DEFFAUD C, GOFFARD A, ROUILLÉ Y, DUBUISSON J, ROINGEARD P, ALIOUAT-DENIS C-M, COCQUEREL L. The endocytic recycling compartment serves as a viral factory for hepatitis E virus. Cell Mol Life Sci 2022, 79: 615.
24. MAQUART M, MARLET J. Rapid SARS-CoV-2 inactivation by mercury and LED UV-C lamps on different surfaces. Photochem Photobiol Sci 2022, 12:2243-2247.
25. PLANAS D, STAROPOLI I, POROT F, GUIVEL-BENHASSINE F, HANDALA L, PROT M, BOLLAND WH, PUECH J, PÉRÉ H, VEYER D, SÈVE A, SIMON-LORIÈRE E, BRUEL T, PRAZUCK T, STEFIC K, HOCQUELOUX L, SCHWARTZ O. Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection. Med (NY). 2022, 3: 838-847e3.
26. BRUEL T, STÉFIC K, NGUYEN Y, TONIUTTI D, STAROPOLI I, PORROT F, GUIVEL-BENHASSINE F, BOLLAND WH, PLANAS D, HADJADJ J, HANDALA L, PLANCHAIS C, PROT M, SIMON-LORIÈRE E, ANDRÉ E, BAELE G, CUYPERS L, MOUTHON L, MOUQUET H, BUCHRIESER J, SÈVE A, PRAZUCK T, MAES P, TERRIER B, HOCQUELOUX L, SCHWARTZ O. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies. Cell Rep Med 2022, 3:100850.
2. BEAUMONT E*, LAROCHETTE V*, PRESSER L, MIOT C, PIGNON P, BLANCHARD S, HANSEN BJ, DAUVÉ J, POLI C, PORANEN M, LAMOURETTE P, PLAISANCE M MOREL A, FICKENSCHER H, JEANNIN P, ROINGEARD P*, DELNESTE Y*. IL-26 inhibits hepatitis C virus replication in hepatocytes. J Hepatol 2022 ; 76: 822-831.
3. MALLET C, COCHARD J, LECLERCQ S, TRAPP-FRAGNET L, CHOUTEAU P, DENESVRE C. Hypoxia and HIF-1 Trigger Marek's Disease Virus Reactivation in Lymphoma-Derived Latently Infected T Lymphocytes. J Virol 2022; 96: e0142721.
4. DUFLOO J, PLANCHAIS C, FRÉMONT S, LORIN V, GUIVEL-BENHASSINE, STEFIC K, CASARTELLI N, ECHARD A, ROINGEARD P, MOUQUET H SCHWARTZ O, BRUEL T. Anti-HIV-1 broadly neutralizing antibodies tether viral particles at the surface of infected cells. Nature Com 2022 ; 13:630.
5. HERRSCHER C, EYMIEUX S, GABORIT C, BLASCO H, MARLET J, STEFIC K, ROINGEARD P, GRAMMATICO-GUILLON L, HOURIOUX C. ELISA-based analysis reveals an anti-SARC-CoV-2 protein immune response profile associated with disease severity. J Clin Med 2022 : 11:405.
6. DELAYE JB, ALARCAN H, VALLET N, VEYRAT-DUREBEX C, BERNARD L, HÉRAULT O, ROPERT M, MARLET J, GYAN E, ANDRES C, BLASCO H, PIVER E. Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2. J Investig Med 2022; 70:934-938.
7. LORIN V, FERNÁNDEZ I, MASSE-RANSON G, BOUVIN-PLEY M, MOLINOS-ALBERT LM, PLANCHAIS C, HIEU T, PÉHAU-ARNAUDET G, HREBÍK D, GIRELLI-ZUBANI G, FIQUET O, GUIVEL-BENHASSINE F, SANDERS RW, WALKER BD, SCHWARTZ O, SCHEID JF, DIMITROV JD, PLEVKA P, BRAIBANT M, SEAMAN MS, BONTEMS F, DI SANTO JP, REY FA, MOUQUET H. Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller. J Exp Med 2022, 219:e20212045.
8. WANG C, SCHLUB TE, YU WH, TAN CS, STEFIC K, GIANELLA S, SMITH DM, LAUFFENBURGER DA, CHAILLON A, JULG B. Landscape of HIV neutralization susceptibilities across tissue reservoirs. Clin Infect Dis 2022, in press
9. ZHONG L, SONG Y, MARZIALI F, UZBEKOV R, NGUYEN X-N, JOURNO C, ROINGEARD P, CIMARELLI A. A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway. Life Sci Alliance 2022, 5, e202101174.
10. TREGUIER Y, BULL-MAURER A, ROINGEARD P. Apolipoprotein E, a crucial cellular protein in the lifecycle of hepatitis viruses. Int J Molec Sci 2022, 23:3676.
11. ZERBIB Y, GUILAIN N, EYMIEUX S, UZBEKOV R, CASTELLAIN S, BLANCHARD E, FRANÇOIS C, CHATELAIN D, BRAULT C, MAIZEL J, ROINGEARD P, SLAMA M. Pathology assessments of multiple organs in fatal COVID-19 in ICU vs non-ICU patients. Front Med (Lausanne) 2020, 9:837258.
12. AICHER S-M, STRIECHER F, CHAZAL M, PLANAS D, LUO D, BUCHRIESER J, NEMCOVA M, SEIDLOVA V, ZUKAL J, SERRA-COBO J, PONTIER D, PAIN B, ZIMMER G, SCHWARTZ O, ROINGEARD P, PIKULA J, DACHEUX L, JOUVENENT N. Species-specific molecular barriers to SARS-CoV-2 replication in bat cells. J Virol 2022, 96, e0060822.
13. EYMIEUX S, HOURIOUX C, MARLET J, MOREAU A, PATIENT R, D'ALTEROCHE L, GAUDY-GRAFFIN C, BLANCHARD E, ROINGEARD P. A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype. J Viral Hepat 2022, 29, 719-726.
14. ROINGEARD P, EYMIEUX S, BURLAUD-GAILLARD J, HOURIOUX C, PATIENT R, BLANCHARD E. The double-membrane vesicle (DMV) : a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses. Cell Mol Life Sci 2022, 79:425.
15. NICOLAS A, MIGRAINE J, DUTRIEUX J, SALMONA M, TAUZIN A, HACHIYA A, ESTAQUIER J, MOLINA JM, CLAVEL F, HANCE AJ, MAMMANO F. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients. Microbiol Spectr 2022, e0078422.
16. TRÉGUIER Y, COCHARD J, BURLAUD-GAILLARD J, LEMOINE R, CHOUTEAU P, ROINGEARD P, MEUNIER J-C, MAQUART M. The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particle. Virology J 2022, 19:124.
17. ANDRÉ S, PICARD M, CEZAR ., ROUX-DALVAI F, ALLEAUME-BUTEAUX A, SOUNDARAMOURTY C, SANTA CRUZ A, MENDES-FRIAS A, GOTTI C, LECLERCQ ., NICOLAS A, TAUZIN A, CARVALHO A, CAPELA C, PEDROSA J, GIL CASTRO A, KUNDURA L, LOUBET P, SOTTO A, MULLER L. LEFRANT J-Y, ROGER C, CLARET P-G, DUVNJAK S, TRAN T-A, RACINE G, ZGHIDI-ABOUZID O, NIOCHE P, SILVESTRE R, DROIT A, MAMMANO F, CORBEAU P, AND ESTAQUIER J T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ 2022, 29:1486-1499.
18. ANDRE S, AZARIAS DA SILVA M, PICARD M, ALLEAUME-BUTEAU A, KUNDURA L, CEZAR R, SOUNDARAMOURTY C, SANTA CRUZ A, MENDES-FRIAS A, CARVALHO A, CAPELA C, PEDROSA J, GIL CASTRO A, LOUBET P, MULLER L, SOTTO A, LEFRANT J-Y, ROGER C, CLARET P-G, DUVNJAK S, TRAN T-H, ZGHIDI-ABOUZID O, NIOCHE P, SILVESTRE R, CORBEAU P, MAMMANO F, ESTAQUIER J. Low quantity and quality of anti-spike humoral response is linked to CD4 T cell apoptosis in COVID-19 patients. Cell Death Disease, 2022, 13:741.
19. ZOLADEK J, BURLAUD-GAILLARD J, CHAZAL M, DESGRAUPES S, JEANNIN P, GESSAIN A, PARDIGON N, HUBERT M, ROINGEARD P, JOUVENET N, AFONSO P. Human claudin-derived peptides inhibit the fusion process of Zika virus and are broad Flavivirus inhibitors. Microbiology Spectrum 2022, 10:e0298922.
20. GALLO G, KOTLIK P, ROINGEARD P, MONOT M, CHEVREUX G, ULRICH RG, TORDO N, ERMONVAL M. The diverse susceptibilities and responses of human and rodent cells to orthohantavirus infection reveal different levels of cellular restriction. PloS Negl Trop Dis 2022, 16: e0010844.
21. BOYARD J, CAILLE A, BRUNET-HOUDARD S, SENGCHANH-VIDAL S, GIRAUDEAU B, MARRET H, ROLLAND-LOZACHMEUR G, RUSCH E, GAUDY-GRAFFIN C, HAGUENOER K. A home-mailed versus general practitioner-delivered vaginal self-sampling kit for cervical cancer screening: a cluster randomized controlled trial with a cost-effectiveness analysis. J Womens Health (Larchmt) 2022, 31:1472-1480.
22. MANRY J, BASTARD P, GERVAIS A,... (100 co-authors), MARLET J, ....(71 co-authors), Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A. Proc Natl Acad Sci USA 2022, 119: e2200413119.
23. BENTALEB C, HERVOUET K, MONTPELLIER C, CAMUZEL C, FERRIÉ M, BURLAUD-GAILLARD J, BRESSANELLI S, METZGER K, WERKMEISTER E, ANKAVAY M, LEON-JANAMPA N, MARLET J, ROUX J, DEFFAUD C, GOFFARD A, ROUILLÉ Y, DUBUISSON J, ROINGEARD P, ALIOUAT-DENIS C-M, COCQUEREL L. The endocytic recycling compartment serves as a viral factory for hepatitis E virus. Cell Mol Life Sci 2022, 79: 615.
24. MAQUART M, MARLET J. Rapid SARS-CoV-2 inactivation by mercury and LED UV-C lamps on different surfaces. Photochem Photobiol Sci 2022, 12:2243-2247.
25. PLANAS D, STAROPOLI I, POROT F, GUIVEL-BENHASSINE F, HANDALA L, PROT M, BOLLAND WH, PUECH J, PÉRÉ H, VEYER D, SÈVE A, SIMON-LORIÈRE E, BRUEL T, PRAZUCK T, STEFIC K, HOCQUELOUX L, SCHWARTZ O. Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection. Med (NY). 2022, 3: 838-847e3.
26. BRUEL T, STÉFIC K, NGUYEN Y, TONIUTTI D, STAROPOLI I, PORROT F, GUIVEL-BENHASSINE F, BOLLAND WH, PLANAS D, HADJADJ J, HANDALA L, PLANCHAIS C, PROT M, SIMON-LORIÈRE E, ANDRÉ E, BAELE G, CUYPERS L, MOUTHON L, MOUQUET H, BUCHRIESER J, SÈVE A, PRAZUCK T, MAES P, TERRIER B, HOCQUELOUX L, SCHWARTZ O. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies. Cell Rep Med 2022, 3:100850.
Contact
Inserm - U1259 MAVIVH
10 boulevard Tonnellé - BP 3223
37032 Tours Cedex 1 - France
Tél. : 33 (2) 47 36 61 27
Fax : 33 (2) 47 36 61 26
Deputy Administrator
Head : Philippe ROINGEARD
Deputy Head : Denys Brand
Deputy Head : Fabrizio Mammano